MedPath

BENZOCAINE 20% / LIDOCAINE 10% / TETRACAINE 10%

BENZOCAINE 20% / LIDOCAINE 10% / TETRACAINE 10%

Approved
Approval ID

897fba62-e2f2-b4df-e053-2995a90aaf60

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 22, 2019

Manufacturers
FDA

Sincerus Florida, LLC

DUNS: 080105003

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

BENZOCAINE 20% / LIDOCAINE 10% / TETRACAINE 10%

PRODUCT DETAILS

NDC Product Code72934-2009
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationTOPICAL
Effective DateMay 22, 2019
Generic NameBENZOCAINE 20% / LIDOCAINE 10% / TETRACAINE 10%

INGREDIENTS (3)

BENZOCAINEActive
Quantity: 20 g in 100 g
Code: U3RSY48JW5
Classification: ACTIB
LIDOCAINEActive
Quantity: 10 g in 100 g
Code: 98PI200987
Classification: ACTIB
TETRACAINEActive
Quantity: 10 g in 100 g
Code: 0619F35CGV
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BENZOCAINE 20% / LIDOCAINE 10% / TETRACAINE 10% - FDA Drug Approval Details